14.72 USD
▼-0.26-1.74%
盘后 15.85 0.00%
2026-11-19
市值
$1.55B
市盈率
—
EPS
-1.17
股息率
—
52 周区间
4.96 – 18.89
成交量
2.76M
Beta
2.36
目标价
15.17
52W 低 4.9652W 高 18.89
价格走势
公司简介
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample....